10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
46.27
-1.79 (-3.72%)
At close: Jul 24, 2026, 4:00 PM EDT
46.01
-0.26 (-0.56%)
After-hours: Jul 24, 2026, 7:57 PM EDT
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $5.87 billion as of July 24, 2026. Its market cap has increased by 250.27% in one year.
Market Cap
5.87B
Enterprise Value
5.42B
1-Year Change
250.27%
Ranking
Category
Stock Price
$46.27
ChartMarket Cap Chart
Since September 12, 2019, 10x Genomics's market cap has increased from $4.95B to $5.87B, an increase of 18.66%. That is a compound annual growth rate of 2.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 5.87B | 184.59% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veeva Systems | 29.17B |
| BrightSpring Health Services | 14.55B |
| Tempus AI | 8.28B |
| HealthEquity | 7.89B |
| Hinge Health | 5.93B |
| Waystar Holding | 4.14B |
| Doximity | 3.68B |
| Privia Health Group | 3.15B |